Log In
BCIQ
Print this Print this
 

UR-67767

  Manage Alerts
Collapse Summary General Information
Company Palau Pharma S.A.
DescriptionBalanced janus kinase inhibitor
Molecular Target Janus kinase (JAK)
Mechanism of ActionJanus kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today